Clinical trial
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With…
NCT00478270 · Hoffmann-La Roche, Industry · Withdrawn
Key facts
| NCT number | NCT00478270 |
|---|---|
| Title | A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease. |
| Official title | An Open Label Study to Assess the Effect of Intravenous Loading Doses of Bondronat on Metastatic Bone Pain in Patients With Breast Cancer and Skeletal Metastases. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain, Bone Neoplasm, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | ibandronate [Bondronat] |
| Enrollment | 0 |
| Start date | Jun 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | May 24, 2007 |
| Last update posted | Aug 16, 2017 |
| Countries | Greece |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: